| The placenta is a niche for hematopoietic stem cells C Gekas, F Dieterlen-Lièvre, SH Orkin, HKA Mikkola Developmental cell 8 (3), 365-375, 2005 | 848 | 2005 |
| The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation KE Rhodes, C Gekas, Y Wang, CT Lux, CS Francis, DN Chan, S Conway, ... Cell stem cell 2 (3), 252-263, 2008 | 392 | 2008 |
| CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age C Gekas, T Graf Blood, The Journal of the American Society of Hematology 121 (22), 4463-4472, 2013 | 339 | 2013 |
| Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages K Schenke-Layland, KE Rhodes, E Angelis, Y Butylkova, ... Stem cells 26 (6), 1537-1546, 2008 | 327 | 2008 |
| Placenta as a site for hematopoietic stem cell development HKA Mikkola, C Gekas, SH Orkin, F Dieterlen-Lievre Experimental hematology 33 (9), 1048-1054, 2005 | 180 | 2005 |
| Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)–dependent window during hematopoietic stem-cell development TM Schlaeger, HKA Mikkola, C Gekas, HB Helgadottir, SH Orkin Blood 105 (10), 3871-3874, 2005 | 127 | 2005 |
| Critical role of FLT3 ligand in IL-7 receptor–independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors E Sitnicka, N Buza-Vidas, H Ahlenius, CM Cilio, C Gekas, JM Nygren, ... Blood, The Journal of the American Society of Hematology 110 (8), 2955-2964, 2007 | 83 | 2007 |
| β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1 C Gekas, T D’Altri, R Aligué, J González, L Espinosa, A Bigas Leukemia 30 (10), 2002-2010, 2016 | 75 | 2016 |
| Hematopoietic stem cell development in the placenta C Gekas, KE Rhodes, B Van Handel, A Chhabra, M Ueno, HKA Mikkola The International journal of developmental biology 54, 1089, 2010 | 73 | 2010 |
| Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis C Gekas, KE Rhodes, LM Gereige, H Helgadottir, R Ferrari, SK Kurdistani, ... Blood, The Journal of the American Society of Hematology 113 (15), 3461-3471, 2009 | 61 | 2009 |
| Induced pluripotent stem cell–derived human platelets: one step closer to the clinic C Gekas, T Graf Journal of Experimental Medicine 207 (13), 2781-2784, 2010 | 42 | 2010 |
| Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms MA Spinner, A Aleshin, MT Santaguida, SA Schaffert, JL Zehnder, ... Blood advances 4 (12), 2768-2778, 2020 | 28 | 2020 |
| DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis E Svensson, H Eriksson, C Gekas, T Olofsson, J Richter, U Gullberg Experimental cell research 308 (1), 211-221, 2005 | 27 | 2005 |
| The transcription factor NFAT5 limits infection-induced type I interferon responses H Huerga Encabo, L Traveset, J Argilaguet, A Angulo, E Nistal-Villán, ... Journal of Experimental Medicine 217 (3), e20190449, 2019 | 17 | 2019 |
| Isolation and analysis of hematopoietic stem cells from the placenta C Gekas, KE Rhodes, HKA Mikkola JoVE (Journal of Visualized Experiments), e742, 2008 | 13 | 2008 |
| Isolation and visualization of mouse placental hematopoietic stem cells C Gekas, KE Rhodes, H KA Mikkola Current protocols in stem cell biology 6 (1), 2A. 8.1-2A. 8.14, 2008 | 10 | 2008 |
| β‐Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T‐cell acute lymphoblastic leukemia V García‐Hernández, D Arambilet, Y Guillén, T Lobo‐Jarne, M Maqueda, ... EMBO Molecular Medicine 15 (2), e16554, 2023 | 2 | 2023 |
